- Home
- RCKT vs MVBF Comparison
RCKT vs MVBF Comparison
Compare RCKT & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCKT | MVBF |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.6M | 327.4M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | RCKT | MVBF |
|---|---|---|
| Price | $3.04 | $26.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $29.73 | $29.50 |
| AVG Volume (30 Days) | ★ 2.0M | 40.1K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | N/A | ★ 34.64 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $3,400,000.00 |
| Revenue This Year | N/A | $1.70 |
| Revenue Next Year | $64.28 | $13.59 |
| P/E Ratio | ★ N/A | $68.56 |
| Revenue Growth | N/A | ★ 51.92 |
| 52 Week Low | $2.40 | $19.04 |
| 52 Week High | $5.45 | $29.59 |
Technical Indicators
Market Signals| Indicator | RCKT | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 62.17 |
| Support Level | $2.96 | $25.40 |
| Resistance Level | $3.52 | $27.49 |
| Average True Range (ATR) | 0.19 | 0.70 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 19.27 | 96.56 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About MVBF MVB Financial Corp.
MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.